Header cover image

Japanese (NIKKEI) Pharma Industry Analysis

UpdatedNov 21, 2024
DataAggregated Company Financials
Companies41
  • 7D-4.5%
  • 3M-11.4%
  • 1Y8.6%
  • YTD7.7%

Over the last 7 days, the Pharma industry has dropped 4.5%, driven by Chugai Pharmaceutical declining 10%. Over the past 12 months, the industry was up 8.6%. Earnings are forecast to grow by 12% annually.

Industry Valuation and Performance

Has the Japanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 21 Nov 2024JP¥41.9tJP¥16.1tJP¥1.4t15.1x29.6x2.6x
Sat, 19 Oct 2024JP¥44.9tJP¥15.6tJP¥1.2t15.8x37.4x2.9x
Mon, 16 Sep 2024JP¥44.1tJP¥15.5tJP¥1.2t17.6x36.7x2.8x
Wed, 14 Aug 2024JP¥44.3tJP¥15.5tJP¥1.2t16.5x36.9x2.8x
Fri, 12 Jul 2024JP¥45.6tJP¥15.0tJP¥1.1t18.9x41.6x3x
Sun, 09 Jun 2024JP¥41.2tJP¥15.0tJP¥1.1t17.9x37.6x2.7x
Tue, 07 May 2024JP¥41.3tJP¥14.9tJP¥1.3t18.8x33x2.8x
Thu, 04 Apr 2024JP¥41.2tJP¥15.1tJP¥1.2t18.9x33.9x2.7x
Sat, 02 Mar 2024JP¥43.4tJP¥15.1tJP¥1.2t20x35.7x2.9x
Mon, 29 Jan 2024JP¥40.5tJP¥15.2tJP¥1.4t20.3x29.5x2.7x
Wed, 27 Dec 2023JP¥38.7tJP¥15.2tJP¥1.4t19.3x28.1x2.6x
Fri, 24 Nov 2023JP¥39.3tJP¥15.2tJP¥1.4t20.2x28.6x2.6x
Sun, 22 Oct 2023JP¥38.7tJP¥14.9tJP¥1.4t23.3x27.1x2.6x
Tue, 19 Sep 2023JP¥41.4tJP¥14.9tJP¥1.4t24.9x29x2.8x
Thu, 17 Aug 2023JP¥40.2tJP¥14.9tJP¥1.4t22.8x28.2x2.7x
Sat, 15 Jul 2023JP¥37.4tJP¥14.6tJP¥1.5t20x25.5x2.6x
Mon, 12 Jun 2023JP¥41.3tJP¥14.6tJP¥1.5t20x28.2x2.8x
Wed, 10 May 2023JP¥39.4tJP¥14.5tJP¥1.4t18.8x27.8x2.7x
Fri, 07 Apr 2023JP¥37.1tJP¥14.3tJP¥1.5t17.1x25.3x2.6x
Sun, 05 Mar 2023JP¥36.8tJP¥14.3tJP¥1.5t16.6x25.1x2.6x
Tue, 31 Jan 2023JP¥36.9tJP¥13.7tJP¥1.4t19.3x27.3x2.7x
Thu, 29 Dec 2022JP¥37.8tJP¥13.7tJP¥1.3t18.2x28x2.8x
Sat, 26 Nov 2022JP¥40.1tJP¥13.7tJP¥1.3t19.5x29.7x2.9x
Mon, 24 Oct 2022JP¥37.9tJP¥13.3tJP¥1.4t17.1x26.4x2.8x
Wed, 21 Sep 2022JP¥36.9tJP¥13.3tJP¥1.4t17.7x25.8x2.8x
Fri, 19 Aug 2022JP¥37.6tJP¥13.3tJP¥1.4t18.2x26.2x2.8x
Sun, 17 Jul 2022JP¥37.6tJP¥13.1tJP¥1.5t19.7x25.7x2.9x
Tue, 14 Jun 2022JP¥34.4tJP¥13.1tJP¥1.5t18x23.5x2.6x
Thu, 12 May 2022JP¥34.9tJP¥13.0tJP¥1.6t16.7x21.2x2.7x
Sat, 09 Apr 2022JP¥35.6tJP¥12.8tJP¥1.5t20.2x23x2.8x
Mon, 07 Mar 2022JP¥32.9tJP¥12.8tJP¥1.5t18.2x21.3x2.6x
Wed, 02 Feb 2022JP¥32.4tJP¥12.5tJP¥1.6t17.2x20.6x2.6x
Fri, 31 Dec 2021JP¥34.2tJP¥12.5tJP¥1.6t18x21.5x2.7x
Sun, 28 Nov 2021JP¥35.0tJP¥12.5tJP¥1.6t18.6x22x2.8x
Price to Earnings Ratio

22x


Total Market Cap: JP¥35.0tTotal Earnings: JP¥1.6tTotal Revenue: JP¥12.5tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Pharma Industry Price to Earnings3Y Average 28.5x202220232024
Current Industry PE
  • Investors are relatively neutral on the Japanese Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 28.5x.
  • The industry is trading close to its 3-year average PS ratio of 2.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 3.9% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market-0.44%
Healthcare-3.15%
Pharma-4.52%
Pharma-4.52%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4506 Sumitomo PharmaJP¥611.003.4%
+JP¥7.9b
27.3%PS0.7x
4887 Sawai Group HoldingsJP¥1.98k3.2%
+JP¥7.4b
18.4%PE14.6x
4516 Nippon ShinyakuJP¥4.15k2.1%
+JP¥5.8b
-24.0%PE10.7x
4552 JCR PharmaceuticalsJP¥696.007.2%
+JP¥5.7b
-46.7%PS2.4x
4530 Hisamitsu PharmaceuticalJP¥4.30k1.4%
+JP¥4.3b
-6.4%PE21.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4528

JP¥1,752.00

Ono Pharmaceutical

7D

-3.2%

1Y

-37.5%

4503

JP¥1,572.00

Astellas Pharma

7D

-5.7%

1Y

-13.1%

4516

JP¥4,149.00

Nippon Shinyaku

7D

2.1%

1Y

-24.0%

4519

JP¥6,391.00

Chugai Pharmaceutical

7D

-10.4%

1Y

29.4%

4521

JP¥4,431.00

Kaken Pharmaceutical

7D

1.3%

1Y

34.3%

4568

JP¥4,491.00

Daiichi Sankyo Company

7D

-1.3%

1Y

10.7%

4506

JP¥611.00

Sumitomo Pharma

7D

3.4%

1Y

27.3%

4552

JP¥696.00

JCR Pharmaceuticals

7D

7.2%

1Y

-46.7%

4551

JP¥4,685.00

Torii Pharmaceutical

7D

2.9%

1Y

28.0%

4887

JP¥1,978.00

Sawai Group Holdings

7D

3.2%

1Y

18.4%